These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


237 related items for PubMed ID: 23673438

  • 1. Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors.
    Dimitroulas T, Douglas KM, Panoulas VF, Toms T, Smith JP, Treharne GJ, Nightingale P, Hodson J, Kitas GD.
    Clin Rheumatol; 2013 Sep; 32(9):1357-64. PubMed ID: 23673438
    [Abstract] [Full Text] [Related]

  • 2. White coat hypertension and haemostatic/fibrinolytic balance disorders.
    Makris T, Stavroulakis G, Papadopoulos D, Paizis I, Krespi P, Tsoukala C, Hatzizacharias A, Votteas V.
    Eur Cytokine Netw; 2006 Jun; 17(2):137-41. PubMed ID: 16840033
    [Abstract] [Full Text] [Related]

  • 3. The effects of sampling from a peripheral venous catheter compared to repeated venepunctures on markers of coagulation, inflammation, and endothelial function.
    Espenhain Landgrebe L, Schlosser Mose L, Palarasah Y, Sidelmann JJ, Bladbjerg EM.
    Scand J Clin Lab Invest; 2019 Dec; 79(8):584-589. PubMed ID: 31631713
    [Abstract] [Full Text] [Related]

  • 4. The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome.
    Ames PR, Lupoli S, Alves J, Atsumi T, Edwards C, Iannaccone L, Khamashta MA, Hughes GR, Brancaccio V.
    Br J Rheumatol; 1997 Oct; 36(10):1045-50. PubMed ID: 9374919
    [Abstract] [Full Text] [Related]

  • 5. The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
    Chudý P, Kotuličová D, Staško J, Kubisz P.
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):493-8. PubMed ID: 21519232
    [Abstract] [Full Text] [Related]

  • 6. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B, Andersson T, Hallqvist J, Reuterwall C, Ahlbom A, deFaire U.
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [Abstract] [Full Text] [Related]

  • 7. Neonatal haemostatic parameters in correlation to gestational age and birth weight.
    Mitsiakos G, Katsaras GN, Pouliakis A, Papadakis E, Chatziioannidis I, Mitsiakou C, Gialamprinou D, Papacharalampous E, Kioumi A, Athanasiou M, Athanassiadou F, Sfoungaris D, Nikolaidis N.
    Int J Lab Hematol; 2022 Oct; 44(5):952-958. PubMed ID: 35815444
    [Abstract] [Full Text] [Related]

  • 8. Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis.
    Segarra A, Chacón P, Martinez-Eyarre C, Argelaguer X, Vila J, Ruiz P, Fort J, Bartolomé J, Camps J, Moliner E, Pelegrí A, Marco F, Olmos A, Piera L.
    J Am Soc Nephrol; 2001 Jun; 12(6):1255-1263. PubMed ID: 11373350
    [Abstract] [Full Text] [Related]

  • 9. Tissue plasminogen activator, plasminogen activator inhibitor-1 and von Willebrand factor in rheumatoid arthritis.
    Wållberg-Jonsson S, Dahlén GH, Nilsson TK, Rånby M, Rantapää-Dahlqvist S.
    Clin Rheumatol; 1993 Sep; 12(3):318-24. PubMed ID: 8258230
    [Abstract] [Full Text] [Related]

  • 10. Increased plasma fibrinolytic activity in bleeding gastrointestinal angiodysplasia.
    Junquera F, Saperas E, Anglés A, Abadía C, Monasterio J, Malagelada JR.
    Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):199-205. PubMed ID: 15674098
    [Abstract] [Full Text] [Related]

  • 11. Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.
    Lau CS, McLaren M, Hanslip J, Kerr M, Belch JJ.
    Ann Rheum Dis; 1993 Sep; 52(9):643-9. PubMed ID: 8239758
    [Abstract] [Full Text] [Related]

  • 12. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
    Sartorio A, Cattaneo M, Bucciarelli P, Bottasso B, Porretti S, Epaminonda P, Faglia G, Arosio M.
    Exp Clin Endocrinol Diabetes; 2000 Sep; 108(7):486-92. PubMed ID: 11083070
    [Abstract] [Full Text] [Related]

  • 13. Haemostasis in patients with Behçet's disease.
    Demirer S, Sengül N, Yerdel MA, Tüzüner A, Ulus AT, Gürler A, Bergqvist D, Siegbahn A, Karacagil S.
    Eur J Vasc Endovasc Surg; 2000 Jun; 19(6):570-4. PubMed ID: 10873722
    [Abstract] [Full Text] [Related]

  • 14. Haemostasis balance disorders in patients with essential hypertension.
    Makris TK, Tsoukala C, Krespi P, Hatzizacharias A, Gialeraki A, Papargyriou J, Votteas V, Mandalaki T.
    Thromb Res; 1997 Oct 15; 88(2):99-107. PubMed ID: 9361364
    [Abstract] [Full Text] [Related]

  • 15. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S, Cvetkovic JT, Sundqvist KG, Lefvert AK, Rantapää-Dahlqvist S.
    J Rheumatol; 2002 May 15; 29(5):875-82. PubMed ID: 12022343
    [Abstract] [Full Text] [Related]

  • 16. Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI.
    Erem C, Nuhoglu I, Kocak M, Yilmaz M, Sipahi ST, Ucuncu O, Ersoz HO.
    Endocrine; 2008 Jun 15; 33(3):270-6. PubMed ID: 19016004
    [Abstract] [Full Text] [Related]

  • 17. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G, De Mitrio V, Sciaraffia M, Pannacciulli N, Minenna A, Giorgino F, Petronelli M, Laudadio E, Giorgino R.
    Metabolism; 1997 Nov 15; 46(11):1287-93. PubMed ID: 9361687
    [Abstract] [Full Text] [Related]

  • 18. The effect of disease activity related cytokines on the fibrinolytic potential and cICAM-1 expression in rheumatoid arthritis.
    Kamper EF, Kopeikina LT, Trontzas P, Potamianou A, Tsiroglou E, Stavridis JC.
    J Rheumatol; 2000 Nov 15; 27(11):2545-50. PubMed ID: 11093432
    [Abstract] [Full Text] [Related]

  • 19. Effects of Thyroid Function on Hemostasis, Coagulation, and Fibrinolysis: A Mendelian Randomization Study.
    Ellervik C, Mora S, Kuś A, Åsvold B, Marouli E, Deloukas P, Sterenborg RBTM, Teumer A, Burgess S, Sabater-Lleal M, Huffman J, Johnson AD, Trégouet DA, Smith NL, Medici M, DeVries PS, Chasman DI, Kjaergaard AD.
    Thyroid; 2021 Sep 15; 31(9):1305-1315. PubMed ID: 34210154
    [Abstract] [Full Text] [Related]

  • 20. Prothrombin fragment 1 + 2 is associated with intima media thickness of the carotid artery in patients with myocardial infarction.
    Henareh L, Jogestrand T, Agewall S.
    Thromb Res; 2009 Nov 15; 124(5):526-30. PubMed ID: 19427679
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.